| Financial Year |
March 31 2023 |
| Monetary Funds |
397,017,831.29 |
| Held-for-trading Financial Assets |
71,358,851.89 |
| Notes Receivable |
-- |
| Accounts Receivable |
149,317,747.53 |
| Advances to Suppliers |
94,853,640.65 |
| Other Receivables |
2,743,861.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
289,937,628.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,015,181.92 |
| Total Current Assets |
1,031,544,790.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,241,532,050.60 |
| Under-construction Projects |
1,012,537,618.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
349,104,103.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
65,870,366.29 |
| Deferred Income Tax Assets |
1,714,149.82 |
| Other Non-Current Assets |
235,315,588.30 |
| Sub-Total of Non-Current Assets |
2,957,146,141.78 |
| Total Assets |
3,988,690,932.62 |
| Short-Term Loans |
82,774,446.41 |
| Trading Financial liabilities |
1,945,225.00 |
| Notes Payable |
80,461,500.00 |
| Accounts Payable |
361,452,081.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
239,087.43 |
| Taxes Payable |
36,974,340.94 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
117,792,840.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,976,559.18 |
| Other Current Liabilities |
7,058,375.29 |
| Sub-Total of Current Liabilities |
756,969,650.74 |
| Long-term Loans |
542,762,165.36 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
568,062,613.96 |
| Total Liabilities |
1,325,032,264.70 |
| Paid-In Capital(Or Share Stock) |
228,151,400.00 |
| Capital Surplus |
1,061,903,328.66 |
| Surplus Reserve |
76,312,390.96 |
| LESS:Treasury Stock |
65,929,990.91 |
| Undistributed Profits |
1,263,763,829.07 |
| Minority Stockholder's Interest |
94,706,009.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,568,952,658.35 |
| Owner's Equity（Stockholder's Equity） |
2,663,658,667.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,988,690,932.62 |
